Use of udenafil is not associated with a reduction in post-ERCP pancreatitis: Results of a randomized, placebo-controlled, multicenter trial

Gastrointestinal Endoscopy

Volumn 74, Issue 3, 2011, Pages 556-562

  Oh, Hyoung Chul ^a   Cheon, Young Koog ^b   Cho, Young Deok ^c   Do, Jae Hyuk ^a  

^a Chung Ang University College of Medicine   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

^c Soonchunhyang University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; UDENAFIL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CATHETER COMPLICATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG INDUCED HEADACHE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; FLUSHING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PANCREAS FUNCTION DISORDER; PANCREATIC DUCT OPACIFICATION; PANCREATITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; VATER PAPILLA STENOSIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; DOUBLE-BLIND METHOD; HUMANS; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PANCREATITIS; PHOSPHODIESTERASE 5 INHIBITORS; PYRIMIDINES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPHINCTER OF ODDI DYSFUNCTION; SULFONAMIDES; YOUNG ADULT;

EID: 80052266438     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2011.04.047     Document Type: Article

References (33)

1. M.L. Freeman, and N.M. Guda Prevention of post-ERCP pancreatitis: a comprehensive review Gastrointest Endosc 59 2004 845 864 (Pubitemid 38879313)
2. C. Nojgaard, M. Hornum, and M. Elkjaer Does glyceryl nitrate prevent post-ERCP pancreatitis? A prospective, randomized, double-blind, placebo-controlled multicenter trial Gastrointest Endosc 69 2009 e31 e37
3. C.W. Choi, D.H. Kang, and G.H. Kim Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis Gastrointest Endosc 69 2009 e11 e18
4. S. Sherman, W.M. Alazmi, and G.A. Lehman Evaluation of recombinant platelet-activating factor acetylhydrolase for reducing the incidence and severity of post-ERCP acute pancreatitis Gastrointest Endosc 69 2009 462 472
5. T.H. Lee, H. Park do, and J.Y. Park Can wire-guided cannulation prevent post-ERCP pancreatitis? A prospective randomized trial Gastrointest Endosc 69 2009 444 449
6. D.J. van Westerloo, E.A. Rauws, and D. Hommes Pre-ERCP infusion of semapimod, a mitogen-activated protein kinases inhibitor, lowers post-ERCP hyperamylasemia but not pancreatitis incidence Gastrointest Endosc 68 2008 246 254 (Pubitemid 352024382)
7. A.A. Bailey, M.J. Bourke, and S.J. Williams A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis Endoscopy 40 2008 296 301 (Pubitemid 351524377)
8. Y.K. Cheon, K.B. Cho, and J.L. Watkins Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial Gastrointest Endosc 66 2007 1126 1132 (Pubitemid 350179792)
9. D. Kapetanos, G. Kokozidis, and D. Christodoulou A randomized controlled trial of pentoxifylline for the prevention of post-ERCP pancreatitis Gastrointest Endosc 66 2007 513 518 (Pubitemid 47304417)
10. G. Manes, S. Ardizzone, and G. Lombardi Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study Gastrointest Endosc 65 2007 982 987 (Pubitemid 46783824)
11. R. Sotoudehmanesh, M. Khatibian, and S. Kolahdoozan Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP Am J Gastroenterol 102 2007 978 983 (Pubitemid 46698240)
12. A.J. Kaffes, M.J. Bourke, and S. Ding A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: effects on technical success and post-ERCP pancreatitis Gastrointest Endosc 64 2006 351 357 (Pubitemid 44233561)
13. M.L. Freeman, J.A. DiSario, and D.B. Nelson Risk factors for post-ERCP pancreatitis: a prospective, multicenter study Gastrointest Endosc 54 2001 425 434 (Pubitemid 33661145)
14. P.R. Tarnasky, Y.Y. Palesch, and J.T. Cunningham Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction Gastroenterology 115 1998 1518 1524 (Pubitemid 28546003)
15. M.L. Freeman, C. Overby, and D. Qi Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success Gastrointest Endosc 59 2004 8 14 (Pubitemid 38095500)
16. J. Cheung, K.K. Tsoi, and W.L. Quan Guidewire versus conventional contrast cannulation of the common bile duct for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis Gastrointest Endosc 70 2009 1211 1219
17. E. Masci, A. Mariani, and S. Curioni Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis Endoscopy 35 2003 830 834 (Pubitemid 37254216)
18. Y.K. Cheon, K.B. Cho, and J.L. Watkins Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification Gastrointest Endosc 65 2007 385 393 (Pubitemid 46275652)
19. S. Sudhindran, E. Bromwich, and P.R. Edwards Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis Br J Surg 88 2001 1178 1182 (Pubitemid 34015599)
20. A. Andriulli, L. Solmi, and S. Loperfido Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate Clin Gastroenterol Hepatol 2 2004 713 718 (Pubitemid 39013432)
21. K.C. Thomopoulos, N.A. Pagoni, and K.A. Vagenas Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis Gastrointest Endosc 64 2006 726 731 (Pubitemid 44573121)
22. F. Prat, J. Amaris, and B. Ducot Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study Gastrointest Endosc 56 2002 202 208
23. B. Murray, R. Carter, and C. Imrie Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography Gastroenterology 124 2003 1786 1791 (Pubitemid 36666775)
24. B.J. Elmunzer, A.K. Waljee, and G.H. Elta A meta-analysis of NSAIDs in the prevention of post-ERCP pancreatitis Gut 57 2008 1262 1267
25. I. Goldstein, T.F. Lue, and H. Padma-Nathan Oral sildenafil in the treatment of erectile dysfunction Sildenafil Study Group N Engl J Med 338 1998 1397 1404 (Pubitemid 28221980)
26. N. Galie, H.A. Ghofrani, and A. Torbicki Sildenafil citrate therapy for pulmonary arterial hypertension N Engl J Med 353 2005 2148 2157 (Pubitemid 41653106)
27. R. Fries, K. Shariat, and H. von Wilmowsky Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy Circulation 112 2005 2980 2985 (Pubitemid 41612301)
28. A.J. Eherer, I. Schwetz, and H.F. Hammer Effect of sildenafil on oesophageal motor function in healthy subjects and patients with oesophageal motor disorders Gut 50 2002 758 764 (Pubitemid 34539035)
29. Y.K. Cheon, Y.D. Cho, and J.H. Moon Effects of vardenafil, a phosphodiesterase type-5 inhibitor, on sphincter of Oddi motility in patients with suspected biliary sphincter of Oddi dysfunction Gastrointest Endosc 69 2009 1111 1116
30. M.L. Freeman, D.B. Nelson, and S. Sherman Complications of endoscopic biliary sphincterotomy N Engl J Med 335 1996 909 918 (Pubitemid 26314443)
31. P.B. Cotton, G. Lehman, and J. Vennes Endoscopic sphincterotomy complications and their management: an attempt at consensus Gastrointest Endosc 37 1991 383 393
32. B.H. Kim, H.S. Lim, and J.Y. Chung Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects Br J Clin Pharmacol 65 2008 848 854
33. D. Kouvelas, A. Goulas, and G. Papazisis PDE5 inhibitors: in vitro and in vivo pharmacological profile Curr Pharm Des 15 2009 3464 3475